Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pharmacogenomics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
QIAGEN
Bio-Rad Laboratories, Inc
Becton, Dickinson and Company
F Hoffmann-La Roche AG
Abbott Laboratories, Inc
Illumina, Inc
Thermo Fisher Scientific Inc
By Type:
Mass Spectrometry
Others
DNA Sequencing
Polymerase Chain Reaction
Microarray
Electrophoresis
By Application:
Tailored Treatment
Oncology
Other Therapeutic Applications
Drug Discovery
Pain Management
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pharmacogenomics Market Overview 2018-2029
-
1.1 China Pharmacogenomics Industry Development Overview
-
1.2 China Pharmacogenomics Industry Development History
-
1.3 China Pharmacogenomics Industry Market Size (2018-2029)
-
1.4 China Pharmacogenomics Market Analysis by Type from Production Side
-
1.4.1 China Pharmacogenomics Production Volume, Production Value and Growth Rate of Mass Spectrometry (2018-2029)
-
1.4.2 China Pharmacogenomics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Pharmacogenomics Production Volume, Production Value and Growth Rate of DNA Sequencing (2018-2029)
-
1.4.4 China Pharmacogenomics Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (2018-2029)
-
1.4.5 China Pharmacogenomics Production Volume, Production Value and Growth Rate of Microarray (2018-2029)
-
1.4.6 China Pharmacogenomics Production Volume, Production Value and Growth Rate of Electrophoresis (2018-2029)
-
1.5 China Pharmacogenomics Market Analysis by Application from Consumption End
-
1.5.1 China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Tailored Treatment (2018-2029)
-
1.5.2 China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.5.3 China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Other Therapeutic Applications (2018-2029)
-
1.5.4 China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Drug Discovery (2018-2029)
-
1.5.5 China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Pain Management (2018-2029)
-
1.6 China Pharmacogenomics Market Analysis by Region
-
1.6.1 North China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pharmacogenomics Market Size and Growth Rate from 2018-2029
Chapter 2 China Pharmacogenomics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pharmacogenomics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pharmacogenomics Market Status and Competition Analysis in 2023
-
2.2.3 China Pharmacogenomics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pharmacogenomics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pharmacogenomics Industry Development
Chapter 3 PharmacogenomicsIndustry Chain Analysis
-
3.1 Pharmacogenomics Industry Chain
-
3.2 Pharmacogenomics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pharmacogenomics Market
-
3.3 Pharmacogenomics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pharmacogenomics Market
Chapter 4 China Pharmacogenomics Market, by Type
-
4.1 China Pharmacogenomics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pharmacogenomics Total Production Volume and Growth Rate from Production Side
-
4.5 China Pharmacogenomics Production Volume and Growth Rate, by Type
-
4.5.1 China Pharmacogenomics Production Volume and Growth Rate of Mass Spectrometry
-
4.5.2 China Pharmacogenomics Production Volume and Growth Rate of Others
-
4.5.3 China Pharmacogenomics Production Volume and Growth Rate of DNA Sequencing
-
4.5.4 China Pharmacogenomics Production Volume and Growth Rate of Polymerase Chain Reaction
-
4.5.5 China Pharmacogenomics Production Volume and Growth Rate of Microarray
-
4.5.6 China Pharmacogenomics Production Volume and Growth Rate of Electrophoresis
Chapter 5 China Pharmacogenomics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pharmacogenomics Total Market Size and Growth Rate from Consumption End
-
5.5 China Pharmacogenomics Market Size and Growth Rate, by Application
-
5.5.1 China Pharmacogenomics Market Size and Growth Rate of Tailored Treatment
-
5.5.2 China Pharmacogenomics Market Size and Growth Rate of Oncology
-
5.5.3 China Pharmacogenomics Market Size and Growth Rate of Other Therapeutic Applications
-
5.5.4 China Pharmacogenomics Market Size and Growth Rate of Drug Discovery
-
5.5.5 China Pharmacogenomics Market Size and Growth Rate of Pain Management
Chapter 6 China Pharmacogenomics Market, by Region
-
6.1 China Pharmacogenomics Production Volume and Production Value, by Region
-
6.2 China Pharmacogenomics Sales Volume and Sales Value, by Region
Chapter 7 North China Pharmacogenomics Market Analysis
-
7.1 North China Pharmacogenomics Market, by Type
-
7.2 North China Pharmacogenomics Market, by Application
Chapter 8 Central China Pharmacogenomics Market Analysis
-
8.1 Central China Pharmacogenomics Market, by Type
-
8.2 Central China Pharmacogenomics Market, by Application
Chapter 9 South China Pharmacogenomics Market Analysis
-
9.1 South China Pharmacogenomics Market, by Type
-
9.2 South China Pharmacogenomics Market, by Application
Chapter 10 East China Pharmacogenomics Market Analysis
-
10.1 East China Pharmacogenomics Market, by Type
-
10.2 East China Pharmacogenomics Market, by Application
Chapter 11 Northeast China Pharmacogenomics Market Analysis
-
11.1 Northeast China Pharmacogenomics Market, by Type
-
11.2 Northeast China Pharmacogenomics Market, by Application
Chapter 12 Southwest China Pharmacogenomics Market Analysis
-
12.1 Southwest China Pharmacogenomics Market, by Type
-
12.2 Southwest China Pharmacogenomics Market, by Application
Chapter 13 Northwest China Pharmacogenomics Market Analysis
-
13.1 Northwest China Pharmacogenomics Market, by Type
-
13.2 Northwest China Pharmacogenomics Market, by Application
Chapter 14 Company Profiles
-
14.1 QIAGEN
-
14.1.1 QIAGEN Company Profile
-
14.1.2 QIAGEN Pharmacogenomics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Bio-Rad Laboratories, Inc
-
14.2.1 Bio-Rad Laboratories, Inc Company Profile
-
14.2.2 Bio-Rad Laboratories, Inc Pharmacogenomics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Becton, Dickinson and Company
-
14.3.1 Becton, Dickinson and Company Company Profile
-
14.3.2 Becton, Dickinson and Company Pharmacogenomics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 F Hoffmann-La Roche AG
-
14.4.1 F Hoffmann-La Roche AG Company Profile
-
14.4.2 F Hoffmann-La Roche AG Pharmacogenomics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Abbott Laboratories, Inc
-
14.5.1 Abbott Laboratories, Inc Company Profile
-
14.5.2 Abbott Laboratories, Inc Pharmacogenomics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Illumina, Inc
-
14.6.1 Illumina, Inc Company Profile
-
14.6.2 Illumina, Inc Pharmacogenomics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Thermo Fisher Scientific Inc
-
14.7.1 Thermo Fisher Scientific Inc Company Profile
-
14.7.2 Thermo Fisher Scientific Inc Pharmacogenomics Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pharmacogenomics Industry Research Conclusions
-
15.2 Pharmacogenomics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pharmacogenomics Industry Market Size (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of Mass Spectrometry (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of DNA Sequencing (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of Microarray (2018-2029)
-
Figure China Pharmacogenomics Production Volume, Production Value and Growth Rate of Electrophoresis (2018-2029)
-
Figure China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Tailored Treatment (2018-2029)
-
Figure China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Other Therapeutic Applications (2018-2029)
-
Figure China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Drug Discovery (2018-2029)
-
Figure China Pharmacogenomics Sales Volume, Sales Value and Growth Rate of Pain Management (2018-2029)
-
Figure North China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure Central China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure South China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure East China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pharmacogenomics Market Size and Growth Rate from 2018-2029
-
Figure Pharmacogenomics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pharmacogenomics Market Share by Type in 2018
-
Figure China Pharmacogenomics Market Share by Type in 2023
-
Figure China Pharmacogenomics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of Mass Spectrometry (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of DNA Sequencing (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of Polymerase Chain Reaction (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of Microarray (2018-2023)
-
Figure China Pharmacogenomics Production Volume and Growth Rate of Electrophoresis (2018-2023)
-
Figure China Pharmacogenomics Market Share by Application in 2018
-
Figure China Pharmacogenomics Market Share by Application in 2023
-
Figure China Pharmacogenomics Total Market Size and Growth Rate from Consumption End
-
Figure China Pharmacogenomics Market Size and Growth Rate of Tailored Treatment (2018-2023)
-
Figure China Pharmacogenomics Market Size and Growth Rate of Oncology (2018-2023)
-
Figure China Pharmacogenomics Market Size and Growth Rate of Other Therapeutic Applications (2018-2023)
-
Figure China Pharmacogenomics Market Size and Growth Rate of Drug Discovery (2018-2023)
-
Figure China Pharmacogenomics Market Size and Growth Rate of Pain Management (2018-2023)
-
Table China Pharmacogenomics Production Volume by Region (2018-2023)
-
Table China Pharmacogenomics Production Volume Share by Region (2018-2023)
-
Figure China Pharmacogenomics Production Volume Share by Region (2018-2023)
-
Table China Pharmacogenomics Production Value by Region (2018-2023)
-
Table China Pharmacogenomics Production Value Share by Region (2018-2023)
-
Figure China Pharmacogenomics Production Value Share by Region (2018-2023)
-
Table China Pharmacogenomics Sales Volume by Region (2018-2023)
-
Table China Pharmacogenomics Sales Volume Share by Region (2018-2023)
-
Figure China Pharmacogenomics Sales Volume Share by Region (2018-2023)
-
Table China Pharmacogenomics Sales Value by Region (2018-2023)
-
Table China Pharmacogenomics Sales Value Share by Region (2018-2023)
-
Figure China Pharmacogenomics Sales Value Share by Region (2018-2023)
-
Table North China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table North China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure North China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table North China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table North China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure North China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table Central China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table Central China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure Central China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table Central China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table Central China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure Central China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table South China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table South China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure South China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table South China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table South China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure South China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table East China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table East China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure East China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table East China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table East China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure East China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table Northeast China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table Northeast China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table Northeast China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table Southwest China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table Southwest China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table Southwest China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pharmacogenomics Production Volume by Type (2018-2023)
-
Table Northwest China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pharmacogenomics Production Volume Share by Type (2018-2023)
-
Table Northwest China Pharmacogenomics Sales Volume by Application (2018-2023)
-
Table Northwest China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pharmacogenomics Sales Volume Share by Application (2018-2023)
-
Table QIAGEN Company Profile
-
Table QIAGEN Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table Bio-Rad Laboratories, Inc Company Profile
-
Table Bio-Rad Laboratories, Inc Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table Becton, Dickinson and Company Company Profile
-
Table Becton, Dickinson and Company Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche AG Company Profile
-
Table F Hoffmann-La Roche AG Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table Abbott Laboratories, Inc Company Profile
-
Table Abbott Laboratories, Inc Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table Illumina, Inc Company Profile
-
Table Illumina, Inc Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
Table Thermo Fisher Scientific Inc Company Profile
-
Table Thermo Fisher Scientific Inc Pharmacogenomics Revenue, Price and Gross (2018-2023)
-
